Cargando…

Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience

BACKGROUND: C3 glomerulopathy (C3GP) is characterized by deposition of complement C3 with absence/traces of immunoglobulins in the glomeruli and categorized into dense deposit disease (DDD), C3 glomerulonephritis (C3GN), complement factor H related protein 5(CFHR5) nephropathy etc. Collaborative eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Viswanathan, Ganesh Kumar, Nada, Ritambhra, Kumar, Ashwani, Ramachandran, Raja, Rayat, Charan Singh, Jha, Vivekanand, Sakhuja, Vinay, Joshi, Kusum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382928/
https://www.ncbi.nlm.nih.gov/pubmed/25889427
http://dx.doi.org/10.1186/s13000-015-0233-0
_version_ 1782364646787776512
author Viswanathan, Ganesh Kumar
Nada, Ritambhra
Kumar, Ashwani
Ramachandran, Raja
Rayat, Charan Singh
Jha, Vivekanand
Sakhuja, Vinay
Joshi, Kusum
author_facet Viswanathan, Ganesh Kumar
Nada, Ritambhra
Kumar, Ashwani
Ramachandran, Raja
Rayat, Charan Singh
Jha, Vivekanand
Sakhuja, Vinay
Joshi, Kusum
author_sort Viswanathan, Ganesh Kumar
collection PubMed
description BACKGROUND: C3 glomerulopathy (C3GP) is characterized by deposition of complement C3 with absence/traces of immunoglobulins in the glomeruli and categorized into dense deposit disease (DDD), C3 glomerulonephritis (C3GN), complement factor H related protein 5(CFHR5) nephropathy etc. Collaborative efforts of pathologists, complement biologists and nephrologists worldwide are expanding the histomorphological pattern and laboratory findings related to C3GP. Hence, we studied point prevalence and morphological spectrum of C3GP in Indian patients to correlate morphological patterns with standard therapies and outcome of the patients. METHODS: Retrospective analysis of renal biopsies (2007-2012,n-4565), which on immunofluorescence (IF) had C3 dominant deposits with absence or trace amount of immunoglobulin was carried out. Histopathology and electronmicroscopy (EM) were reviewed; cases were re-classified as DDD and C3GN. Histomorphological patterns of both groups were compared and correlated with treatment. Clinical details and follow up of patients were retrieved from the department of nephrology. RESULTS: There were 31 cases (0.7%) of C3GP sub-classified as DDD (n-13) and C3GN (n-14). It was difficult to sub-classify 4 cases since EM showed overlapping features. C3GN and DDD had distinct clinical characteristics and disease outcome, though pathological features were overlapping. Majority of C3GP patients were males and were in 2(nd) to 4(th) decade of life. Nephrotic syndrome in DDD and nephritic-nephrotic presentation in C3GN patients was more common. Hypertension and oliguria were more often observed in C3GN than DDD. Membranoproliferative pattern (MPGN) was commonest pattern in DDD; other patterns seen were mesangial proliferative, mesangial expansive/nodular, exudative and crescentic. C3GN also had all the above patterns, the predominant ones being MPGN and mesangial proliferative. Limited follow-up revealed response to therapy only in C3GN (33%). Progression to ESRD was 33% in DDD and 10% cases in C3GN. CONCLUSION: C3GP comprise 0.7% of all renal biopsies. MPGN pattern was the commonest morphological pattern in DDD whereas MPGN and mesangial proliferative pattern were equally dominant patterns in C3GN. EM of 4 cases (13%) showed intermediate features. Evaluation of alternate complement pathway must be done in all cases to identify the point of dysregulated alternate complement pathway and to confirm the diagnosis in ambiguous cases. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1730070964135632
format Online
Article
Text
id pubmed-4382928
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43829282015-04-03 Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience Viswanathan, Ganesh Kumar Nada, Ritambhra Kumar, Ashwani Ramachandran, Raja Rayat, Charan Singh Jha, Vivekanand Sakhuja, Vinay Joshi, Kusum Diagn Pathol Research BACKGROUND: C3 glomerulopathy (C3GP) is characterized by deposition of complement C3 with absence/traces of immunoglobulins in the glomeruli and categorized into dense deposit disease (DDD), C3 glomerulonephritis (C3GN), complement factor H related protein 5(CFHR5) nephropathy etc. Collaborative efforts of pathologists, complement biologists and nephrologists worldwide are expanding the histomorphological pattern and laboratory findings related to C3GP. Hence, we studied point prevalence and morphological spectrum of C3GP in Indian patients to correlate morphological patterns with standard therapies and outcome of the patients. METHODS: Retrospective analysis of renal biopsies (2007-2012,n-4565), which on immunofluorescence (IF) had C3 dominant deposits with absence or trace amount of immunoglobulin was carried out. Histopathology and electronmicroscopy (EM) were reviewed; cases were re-classified as DDD and C3GN. Histomorphological patterns of both groups were compared and correlated with treatment. Clinical details and follow up of patients were retrieved from the department of nephrology. RESULTS: There were 31 cases (0.7%) of C3GP sub-classified as DDD (n-13) and C3GN (n-14). It was difficult to sub-classify 4 cases since EM showed overlapping features. C3GN and DDD had distinct clinical characteristics and disease outcome, though pathological features were overlapping. Majority of C3GP patients were males and were in 2(nd) to 4(th) decade of life. Nephrotic syndrome in DDD and nephritic-nephrotic presentation in C3GN patients was more common. Hypertension and oliguria were more often observed in C3GN than DDD. Membranoproliferative pattern (MPGN) was commonest pattern in DDD; other patterns seen were mesangial proliferative, mesangial expansive/nodular, exudative and crescentic. C3GN also had all the above patterns, the predominant ones being MPGN and mesangial proliferative. Limited follow-up revealed response to therapy only in C3GN (33%). Progression to ESRD was 33% in DDD and 10% cases in C3GN. CONCLUSION: C3GP comprise 0.7% of all renal biopsies. MPGN pattern was the commonest morphological pattern in DDD whereas MPGN and mesangial proliferative pattern were equally dominant patterns in C3GN. EM of 4 cases (13%) showed intermediate features. Evaluation of alternate complement pathway must be done in all cases to identify the point of dysregulated alternate complement pathway and to confirm the diagnosis in ambiguous cases. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1730070964135632 BioMed Central 2015-03-17 /pmc/articles/PMC4382928/ /pubmed/25889427 http://dx.doi.org/10.1186/s13000-015-0233-0 Text en © Viswanathan et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Viswanathan, Ganesh Kumar
Nada, Ritambhra
Kumar, Ashwani
Ramachandran, Raja
Rayat, Charan Singh
Jha, Vivekanand
Sakhuja, Vinay
Joshi, Kusum
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title_full Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title_fullStr Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title_full_unstemmed Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title_short Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
title_sort clinico-pathologic spectrum of c3 glomerulopathy-an indian experience
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382928/
https://www.ncbi.nlm.nih.gov/pubmed/25889427
http://dx.doi.org/10.1186/s13000-015-0233-0
work_keys_str_mv AT viswanathanganeshkumar clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT nadaritambhra clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT kumarashwani clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT ramachandranraja clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT rayatcharansingh clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT jhavivekanand clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT sakhujavinay clinicopathologicspectrumofc3glomerulopathyanindianexperience
AT joshikusum clinicopathologicspectrumofc3glomerulopathyanindianexperience